LONDON, UK / ACCESSWIRE / June 3, 2016 / ActiveWallSt.com announces the list of stocks for today’s research coverage. Pre-market the Active Wall St. team provides the latest corporate, market and technical events impacting selected stocks on the Communication Equipment industry. Companies recently under review include Nokia, QUALCOMM, Ericsson, and Ciena. Register with us now for your free membership and see our complete reports on these equities at:

http://www.activewallst.com/register/

Today, ActiveWallSt.com is promoting its equity research coverage. Get all of our research report free by signing up to http://www.activewallst.com/register/.

Register with us today to access the free research report on these equities at:

http://www.activewallst.com/register/

Nokia Corp. (NYSE: NOK)

Network infrastructure and related services provider, Nokia Corp.’s stock saw a slight correction of 0.18% and finished Thursday’s trading session at $5.66. A total volume of 7.32 million shares was traded. The Company’s shares are trading below their 50-day moving average by 1.34%. Moreover, shares of Nokia have a Relative Strength Index (RSI) of 56.95. On May 25th, 2016, research firm Credit Agricole issued a ratings upgrade from ‘Underperform’ to ‘Outperform’ for the Company’s stock.

QUALCOMM Inc. (NASDAQ: QCOM)

On Thursday, shares in digital communications products and services developer, manufacturer and marketer, QUALCOMM Inc., recorded a trading volume of 9.03 million shares, and ended the session 0.16% higher at $54.88. The stock has gained 9.22% in the last one month, 5.78% in the previous three months, and 11.88% since the start of this year. The Company’s shares are trading 6.48% above their 50-day moving average and 7.54% above their 200-day moving average. Furthermore, shares of QUALCOMM have an RSI of 67.70. On May 17th, 2016, research firm Credit Agricole initiated an ‘Outperform’ rating, issuing a target price of $65 on the Company’s stock.

Telefonaktiebolaget LM Ericsson (NASDAQ: ERIC)

Shares in Telefonaktiebolaget LM Ericsson, which offers telecommunications equipment and related services to mobile and fixed network operators, closed the day at $7.58, gaining 0.26%. The stock recorded a trading volume of 3.72 million shares. The Company’s shares are trading 11.10% below their 50-day moving average. Additionally, shares Telefonaktiebolaget LM Ericsson have an RSI of 35.56.

Ciena Corp. (NYSE: CIEN)

At the closing bell yesterday, shares in Maryland-based communication equipment, software, and services provider, Ciena Corp., edged 12.78% higher at $20.03. A total volume of 15.37 million shares was traded, which was above their three months average volume of 3.52 million shares. The stock has advanced 21.47% in the last one month and 17.89% on an YTD basis. The Company’s shares are trading above their 50-day moving average by 16.11%. Furthermore, shares of Ciena have an RSI of 78.79.

—
Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:
Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom
Email: info@activewallst.com
Phone number:  1-858-257-3144

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 440720

NEW YORK, NY / ACCESSWIRE / June 3, 2016 / Small caps have been having an explosive week thus far. In this article we take a look at three small cap stocks that have been moving substantially higher over the last few trading sessions.

Take Cellectar Biosciences, Inc. (CLRB) for instance; the biopharmaceutical company develops compounds for the treatment, diagnosis, and imaging of cancer. CLRB’s proprietary product candidates include I-124-CLR1404, a small-molecule, broad-spectrum, and cancer-targeting positron emission tomography (PET) imaging agent that is in Phase II clinical trial for glioblastoma.

CLRB recently announced the receipt of a patent for the treatment of cancer stem cells employing the company’s phospholipid drug conjugate delivery platform technology [1] and investors seem to like the news. The stock was up 23% on Thursday.

Eleven Biotherapeutics, Inc. (EBIO), which engages in the discovery and development of protein therapeutics to treat eye diseases primarily in the United States, has seen its fortunes rise in recent trading. On Thursday the stock rallied as high as 34%, closing at $1.78 and drawing admiration from many analysts who cited the stock’s resilience.

Grow Condos, Inc. (GRWC) is making its own noise on the cannabis front. The industry which is growing at an alarming clip has been attracting the best entrepreneurs in America as the next big gold rush gets fully underway.

Grow Condos, Inc. (GRWC) is more than anything else a cannabis real estate play and as such offers perhaps the most dynamic investing opportunity.
GRWC has a very strong property portfolio and manages growing space for cannabis entrepreneurs. In addition to providing essential real estate GRWC offers financing for the purchase and development of properties. The company also offers important technical equipment for the growing process.

>> This Undiscovered Cannabis Real Estate Stock Could Be Poised For A Move Higher <<

Investors at this stage of GRWC’s development as a cannabis real estate company are becoming more and more aware of its growth potential. The company has justified this largely by building out a very strong property portfolio. This includes a 15,000 square foot warehouse in Eagle Point, Oregon which the company manages for Marijuana Growers. GRWC also owns a new project of approximately 42,000 square feet of warehouse condominiums in the Pioneer Business Park in Eugene, Oregon. [3]

GRWC has seemingly turned up the pressure on the competition in its sector. The company currently has a development project that is awaiting approval from city officials of Eugene, Oregon. The slated project in Nuggetville by all accounts will be a major addition to the company’s current portfolio. GRWC in updating shareholders confirmed that the project “will be constructed on 2.65 acres in the Pioneer Business Park in Eugene, Oregon. Grow Condos plans to construct thirty three warehouse units of 1,500 square feet each, totaling approximately 50,000 square feet of warehouse condominiums.” [4]

GRWC is also developing an entirely different type of cannabis real estate. GRWC announced that it is launching a new division which will target the development of cannabis friendly RV Campgrounds/Resorts, These said GRWC, will be built for owner/operators that are establishing a presence in the recreational marijuana marketplace. [5] “Recreational vehicle owners and campers want to be able to enjoy a stress free experience and we feel that in the recreational marijuana states a cannabis friendly resort will draw great interest,” said GRWC CEO Wayne Zallen as part of the release.

In an expanding industry like cannabis timing by companies is everything and GRWC has thrown its hat in the middle of the ring at a perfectly opportune time.
Pennsylvania was the latest US state to legalize cannabis for medical purposes and joins 23 others which include Minnesota, Maryland, New York, and Illinois. [6] Recreational users have the okay to light up ion a few states too. Alaska, Colorado, Oregon, Washington and the District of Columbia all have laws allowing the use of marijuana recreationally.

>> Investors Have Overlooked This Unique Small Cap, Will You? <<

An examination of actual cannabis sales shows why entrepreneurs are fighting to establish themselves in the space. Research firm ArchView Group said that cannabis sales reached $5.4B in 2015 – a 17.4% increase upon the $4.6B sales achieved in the previous year. [7]

The biggest draw for cannabis growers is the recreational sector. Data compiled by researchers suggests shows that recreational users spent nearly $1 billion in 2015; the actual figure of $998M is a major increase upon the $351M spent by recreational users in 2014. Those sales represent a 184% increase and even Colorado, the state that started the recreational revolution, saw sales surpass the $100M in 2015. [8]

These stocks have fertile ground to continue making their big moves. GRWC in particular should be a keen watch-candidate as the cannabis industry looks to move from its infancy and into the almost $100 billion behemoth many are predicting.

About InvestmentResearchReport.com:

InvestmentResearchReport.com is a small cap publication that uncovers extremely undervalued potential investment opportunities that have been overlooked by everyone else.

Disclosure: DO NOT MAKE ANY TRADING DECISIONS UNTIL YOU HAVE READ OUR FULL DISCLAIMER ON OUR WEBSITE: http://www.investmentresearchreport.com/disclaimer/. Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Owners and operators of InvestmentResearchReport.com hold no stocks or bonds in any of the stocks mentioned in this release as of 06/03/2016. We have been compensated for this release. Please read the disclaimer at the link above for full compensation details. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Please visit the Investment Research Report website and review the disclaimer link above for complete risks and disclosures.

[1] http://finance.yahoo.com/news/cellectar-biosciences-announces-uspto-issues-123000600.html
[2] http://finance.yahoo.com/news/eleven-biotherapeutics-reports-first-quarter-113000530.html
[3] http://growcondos.com/
[4] http://finance.yahoo.com/news/grow-condos-nuggetville-100000451.html
[5] http://finance.yahoo.com/news/grow-condos-launching-rv-campground-100000853.html
[6] http://www.thecannabist.co/2016/04/18/pennsylvania-medical-marijuana-law-signed-by-gov-tom-wolf/52209/
[7] http://www.cnbc.com/2016/02/01/legal-us-pot-sales-soar-in-2015.html
[8] http://www.cnbc.com/2016/02/01/legal-us-pot-sales-soar-in-2015.html

SOURCE: InvestmentResearchReport.com

ReleaseID: 440714

LONDON, UK / ACCESSWIRE / June 3, 2016 / ActiveWallSt.com announces the list of stocks for today’s research coverage. Pre-market the Active Wall St. team provides the latest corporate, market and technical events impacting selected stocks on the Processed & Packaged Goods industry. Companies recently under review include Flowers Foods, Kellogg, J. M. Smucker, and Snyder’s-Lance. Register with us now for your free membership and see our complete reports on these equities at:

http://www.activewallst.com/register/

Today, ActiveWallSt.com is promoting its equity research coverage. Get all of our research report free by signing up to http://www.activewallst.com/register/.

Let us take a brief technical look at how each of the companies mentioned above have fared over the last few trading sessions. Get your complimentary research report on these stocks at: http://www.activewallst.com/register/

Flowers Foods Inc. (NYSE: FLO)

At the close on Thursday, shares in Thomasville, Georgia based bakery products producer and marketer, Flowers Foods Inc., saw a slight correction of 0.48%, ending the day at $18.66. The stock recorded a trading volume of 1.43 million shares. The Company’s shares have advanced 6.69% in the previous three months. The stock is trading below its 50-day moving average by 0.36%. Moreover, shares of Flowers Foods have a Relative Strength Index (RSI) of 48.85. On May 26th, 2016, research firm KeyBanc Capital Markets initiated a ‘Sector Weight’ rating for the Company’s stock.

Kellogg Co. (NYSE: K)

Shares in Michigan-based ready-to-eat cereal and convenience foods manufacturer and marketer, Kellogg Co., ended the day at $74.53, which was a slight correction of 0.49%. A total volume of 1.21 million shares was traded. In the previous three months and since the start of this year, the stock has gained 0.25% and 4.51%, respectively. The Company’s shares are trading above their 200-day moving average by 5.17%. Furthermore, shares of Kellogg have an RSI of 45.23.

The J. M. Smucker Co. (NYSE: SJM)

The J. M. Smucker Company is a manufacturer and marketer of branded food products globally. On Thursday, shares in the Company finished 0.52% higher at $130.40 with a total volume of 659,757 shares traded. The stock has advanced 3.35% in the last one month, 2.15% over the previous three months, and 6.83% on an YTD basis. The Company’s shares are trading above their 50-day and 200-day moving averages by 1.87% and 7.55%, respectively. Additionally, shares of J. M. Smucker have an RSI of 61.19. On May 26th, 2016, research firm KeyBanc Capital Markets initiated a ‘Sector Weight’ rating for the Company’s stock.

Snyder’s-Lance Inc. (NYSE: LNCE)

Snyder’s-Lance Inc. is a manufacturer, distributor, marketer, and seller of snack food products in the U.S. The Company’s stock recorded a trading volume of 420,872 shares at the end of yesterday’s session and closed the day at $31.06, which was a slight correction of 0.10%. The stock is trading below its 50-day moving average by 0.56%. The Company’s shares have an RSI at 50.50. On May 26th, 2016, research firm KeyBanc Capital Markets initiated a ‘Sector Weight’ rating for the Company’s stock.

—
Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:
Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom
Email: info@activewallst.com
Phone number:  1-858-257-3144

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 440724

LONDON, UK / ACCESSWIRE / June 3, 2016 / ActiveWallSt.com announces the list of stocks for today’s research coverage. Pre-market the Active Wall St. team provides the latest corporate, market and technical events impacting selected stocks on the Resorts and Casinos industry. Companies recently under review include MGM Resorts, Las Vegas Sands, Carnival, and Wynn Resorts. Register with us now for your free membership and see our complete reports on these equities at:

http://www.activewallst.com/register/

Today, ActiveWallSt.com is promoting its equity research coverage. Get all of our research report free by signing up to http://www.activewallst.com/register/.

There is so much activity going on in the Resorts and Casinos industry, and surfacing opportunities have us sitting back entertained. Let us take a brief technical look at how each of the companies mentioned above have fared over the last few trading sessions. If you want to get to know these stocks better, you can access their full report by clicking below:

http://www.activewallst.com/register/

MGM Resorts International (NYSE: MGM)

MGM Resorts International, through its wholly owned subsidiaries, owns and/or operates casino resorts in the U.S. and China. The Company’s shares gained 2.90%, closing Thursday’s trading session at $24.10. The stock recorded a trading volume of 7.80 million shares, which was above their three months average volume of 6.21 million shares. The Company’s shares have advanced 12.41% in the last month, 18.54% in the previous three months, and 6.07% on an YTD basis. The stock is trading 9.68% above its 50-day moving average and 14.18% above its 200-day moving average. Additionally, shares of MGM Resorts International have a Relative Strength Index (RSI) of 71.05. On May 06th, 2016, research firm Telsey Advisory Group reiterated its ‘Outperform’ rating with an increase of the target price to $27 a share from $26 a share for the Company’s stock.

Las Vegas Sands Corp. (NYSE: LVS)

Nevada-based Las Vegas Sands Corp., together with its subsidiaries, develops, owns, and operates integrated resorts in the U.S. and Asia. On Thursday, shares in the Company recorded a trading volume of 3.56 million shares. The stock gained 0.88%, ending the day at $46.77. The Company’s shares have advanced 2.18% in the last month and 8.12% since the start of this year. The stock is trading above its 200-day moving average by 3.46%. Furthermore, shares of Las Vegas Sands have an RSI of 53.67.

Carnival Corp. (NYSE: CCL)

Florida-based leisure travel and cruise Company, Carnival Corp.’s stock finished the day 0.58% higher at $48.33 and with a total volume of 3.43 million shares traded. The Company’s shares have advanced 1.28% in the previous three months. The stock is trading below its 200-day moving average by 2.31%. Additionally, shares of Carnival have an RSI of 44.17. On May 26th, 2016, research firm Morgan Stanley reiterated its ‘Equal-Weight’ rating with a decrease of the target price to $54 a share from $60 a share for the Company’s stock.

Wynn Resorts Ltd. (NYSE: WYNN)

Shares in Wynn Resorts Ltd, which together with its subsidiaries, develops, owns, and operates destination casino resorts, ended yesterday’s session 2.77% higher at $99.41. The stock recorded a trading volume of 2.98 million shares. The Company’s shares have advanced 5.82% in the last one month, 13.12% over the previous three months, and 45.38% on an YTD basis. The stock is trading 6.65% above its 50-day moving average and 33.06% above its 200-day moving average. Moreover, shares of Wynn Resorts have an RSI of 64.96.

—
Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:
Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom
Email: info@activewallst.com
Phone number:  1-858-257-3144

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 440721

LONDON, UK / ACCESSWIRE / June 3, 2016 / ActiveWallSt.com announces the list of stocks for today’s research coverage. Pre-market the Active Wall St. team provides the latest corporate, market and technical events impacting selected stocks on the Biotechnology industry. Companies recently under review include XOMA, Vericel, Cara Therapeutics, and Regulus Therapeutics. Register with us now for your free membership and see our complete reports on these equities at:

http://www.activewallst.com/register/

Today, ActiveWallSt.com is promoting its equity research coverage. Get all of our research report free by signing up to http://www.activewallst.com/register/.

There are a number of uncertainties enveloping the Biotech industry at present and these include pricing issues and volatility which are putting even more strain on stocks in this space. Investors, nonetheless, believe that the Biotech segment is close to rebounding. Let us take a look at how each of the companies mentioned above have performed over the last few trading sessions. Access the free reports on these stocks by clicking below:
http://www.activewallst.com/register/.

XOMA Corp. (NASDAQ: XOMA)

Shares in California-based development stage biotechnology Company, XOMA Corp., ended Thursday’s session at $0.69, gaining 2.11%. The stock recorded a trading volume of 581,059 shares. The Company’s shares are trading 10.78% below their 50-day moving average. Moreover, shares of XOMA have a Relative Strength Index (RSI) of 42.85.

Vericel Corp. (NASDAQ: VCEL)

Cambridge, Massachusetts headquartered commercial-stage biopharmaceutical Company, Vericel Corp.’s stock closed the day flat at $2.82 with a total volume of 82,795 shares traded. The Company’s shares have advanced 45.36% in the previous three months and 9.30% since the start of this year. The stock is trading 2.93% above its 200-day moving average. Additionally, shares of Vericel have an RSI of 40.85.

Cara Therapeutics Inc. (NASDAQ: CARA)

On Thursday, shares in Shelton, Connecticut based a clinical-stage biopharmaceutical Company, Cara Therapeutics Inc., recorded a trading volume of 738,487 shares. The stock ended the day 5.05% higher at $6.45. The Company’s shares have advanced 5.22% in the past month and 14.36% in the previous three months. The stock is trading above its 50-day moving average by 1.87%. Furthermore, shares of Cara Therapeutics have an RSI of 57.00.

Regulus Therapeutics Inc. (NASDAQ: RGLS)

Regulus Therapeutics Inc. is a biopharmaceutical Company that focuses on the discovery and development of drugs that target RNAs to treat a variety of diseases in the U.S. The Company’s stock climbed 4.03%, finishing yesterday’s session at $6.20 and with a total volume of 709,136 shares traded. The Company’s shares have advanced 13.97% in the last one month. The stock is trading below its 50-day moving average by 2.88%. Additionally, shares of Regulus Therapeutics have an RSI of 53.89.

—
Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:
Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom
Email: info@activewallst.com
Phone number:  1-858-257-3144

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 440723

LONDON, UK / ACCESSWIRE / June 3, 2016 / ActiveWallSt.com announces the list of stocks for today’s research coverage. Pre-market the Active Wall St. team provides the latest corporate, market and technical events impacting selected stocks on the Steel & Iron industry. Companies recently under review include Nucor, Commercial Metals, TimkenSteel, and Reliance Steel & Aluminum. Register with us now for your free membership and see our complete reports on these equities at:

http://www.activewallst.com/register/

Today, ActiveWallSt.com is promoting its equity research coverage. Get all of our research report free by signing up to http://www.activewallst.com/register/.

Weaker demand in China had the global Steel and Iron industry facing its worst month in May 2016, so a number of commodities traders and equity investors have been keeping a close watch on a few stocks in this space. Since the start of June, fluctuations in the industry have narrowed giving investors a glimmer of hope. Let us take a brief technical look at how each of the companies mentioned above have fared over the last few trading sessions. Register now and access these stocks full reports at:
http://www.activewallst.com/register/

Nucor Corp. (NYSE: NUE)

On Thursday, shares in North Carolina-based steel and steel products manufacturer and seller, Nucor Corp., recorded a trading volume of 1.86 million shares. The stock ended the session 0.74% higher at $49.16. The Company’s shares have gained 0.88% in the last one month, 15.92% over the previous three months, and 22.97% since the start of this year. The stock is trading 2.29% above its 50-day moving average and 16.77% above its 200-day moving average. Moreover, shares of Nucor have a Relative Strength Index (RSI) of 60.09. On May 10th, 2016, research firm Rosenblatt reiterated its ‘Neutral’ rating with an increase of the target price to $51 a share from $47 a share for the Company’s stock.

Commercial Metals Co. (NYSE: CMC)

Commercial Metals Co. is a manufacturer, recycler, and marketer of steel and metal products, and related materials and services in the U.S. and globally. The Company’s stock closed the day at $16.97, which was a correction of 2.36%. A total volume of 2.77 million shares was traded, which was above their three months average volume of 1.71 million shares. The Company’s shares have advanced 10.05% in the previous three months and 25.98% on an YTD basis. The stock is trading 12.28% above its 200-day moving average. Additionally, shares of Commercial Metals have an RSI of 48.52. Yesterday, research firms Bank of America/ Merrill issued a ratings downgrade from ‘Neutral’ to ‘Underperform’ for the Company’s stock.

TimkenSteel Corp. (NYSE: TMST)

Shares in TimkenSteel Corp., which is a manufacturer and seller of alloy steel, and carbon and micro-alloy steel products globally, recorded a trading volume of 1.15 million shares, which was higher than their three months average volume of 860,350 shares. The stock ended yesterday’s trading session 0.21% higher at $9.46. The Company’s shares have advanced 5.82% in the previous three months and 12.89% since the start of this year. The stock is trading below its 200-day moving average by 8.64%. Furthermore, shares of TimkenSteel have an RSI of 43.08. On June 01st, 2016, research firm Cowen reiterated its ‘Market Perform’ rating with an increase of the target price to $13 a share from $8 a share for the Company’s stock.

Reliance Steel & Aluminum Co. (NYSE: RS)

Los Angeles, California headquartered metals service center Company, Reliance Steel & Aluminum Co.’s stock finished Thursday’s session 0.20% higher at $74.76 with a total volume of 644,439 shares traded. The Company’s shares have advanced 3.24% in the last one month, 16.08% over the previous three months, and 30.61% since the start of this year. The stock is trading above its 50-day and 200-day moving averages by 4.63% and 22.65%, respectively. Additionally, shares of Reliance Steel & Aluminum have an RSI of 62.56.

—
Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:
Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom
Email: info@activewallst.com
Phone number:  1-858-257-3144

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 440725

TORONTO, ON / ACCESSWIRE / June 3, 2016 / DNI Metals Inc. (CSE: DNI) (OTC: DMNKF) (FSE: DG7N) (“DNI” or the “Company”) DNI adds New Director, Keith Minty, a mining engineer to help with the development of the Vohitsara Graphite Deposit.

Mr. Minty, P. Eng. MBA has more than 30 years professional experience in mineral resource exploration and development in precious and base metals, industrial minerals and coal in Canada and internationally. Mr. Minty has directly involved in the realizing mineral resource projects value by constructing, operating and managing gold and platinum group metal projects. Mr. Minty has been associated with premier mineral resource exploration and developing companies such as Hunter Dickinson Inc., Viceroy Resources, North American Palladium and Thani Investments in many senior operating and management positions. Until 2013, Mr. Minty was the Chief Operating officer for Thani Investment Ltd.,(a private Dubai based Venture Capital Group) and a subsidiary of Thani Emirates Resources Ltd., and was primary responsible for unlocking value from their worldwide mineral resource projects.

Mr. Minty obtained extensive graphite technical and operating experience at both North Coast Industries (now Northern Graphite Corporation) Bissett Creek Graphite and Cal Graphite Corporation (now Ontario Graphite Inc.) Kearney graphite mine and has experience of in the development of several past and new Sri Lanka graphite projects.

Mr. Minty has had the opportunity of conducting Madagascar precious metals project valuations and is knowledgeable of the political and social requirements associated with Madagascar project development and operations.

Mr. Minty is an active member of the board of directors of Auryn Resources Inc. and Callinex Mines Inc. mineral resource companies.

Mr. Minty obtained a B.Sc. in Mining Engineering from Queen’ University in 1978 and a MBA from Athabasca University in 2014.

Paul Gorman has resigned from the board of DNI. The board expresses their appreciation in Mr. Gorman valuable contributions in advancing the company to it’s new operating entity.

DNI’s board of directors approved a debt for equity transaction and is issuing 300,000 shares to a consultant.

In the next 90 days DNI has 437,500 options expiring.  With the addition of a new CFO and three new directors, the board has approved the granting of incentive stock options.

Pursuant to its Stock Option Plan, DNI has granted incentive stock options to certain directors, officers, and consultants of the Company to purchase up to an aggregate of 2,250,000 common shares in the capital stock of the Company. The options are exercisable at a price of $0.06 per common share, on or before June 3, 2021. The company’s approved option plan allows for up to 10% or 3,972,420 options to be issued.

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

DNI — Canadian Securities Exchange
DG7N — Frankfurt
DMNKF — OTC
Issued: 39,724,204

For further information, contact:
DNI Metals Inc. — Dan Weir, President & CEO 416-595-1195
DanWeir@dnimetals.com
Also visit www.dnimetals.com

We seek Safe Harbour. This announcement may include forward looking statements. While these statements represent DNI’s best current judgment, they are subject to risks and uncertainties that could cause actual results to vary, including risk factors listed in DNI’s Annual Information Form and its MD&As, all of which are available from SEDAR and on its website.

SOURCE: DNI Metals Inc. 

ReleaseID: 440726

LOS ANGELES, CA / ACCESSWIRE / June 3, 2016 / Auxilio, Inc. (OTCQB: AUXO), a leading provider of Managed Print Services (MPS) and IT Security for the healthcare industry, today announced that it will be presenting at the 6th Annual LD Micro Invitational on Tuesday, June 7 at 1 PM PST / 4 PM EST. Joseph F. Flynn (CEO and President of Auxilio Inc.) will be giving the presentation and meeting with investors.

The conference will be held at the Luxe Sunset Bel Air Hotel and will feature 195 companies in the small / micro-cap space.

View Auxilio’s profile here: http://www.ldmicro.com/profile/AUXO

Profiles powered by LD Micro – News Compliments of Accesswire

About Auxilio

Since 2004, Auxilio has led the Managed Print Services industry by offering an innovative and customer driven approach for healthcare organizations. Auxilio takes full responsibility for healthcare customers’ on-site print environment through situation assessment, process analysis, strategy development and program implementation. Hospitals and health systems benefit from streamlined and aligned processes and infrastructure that result in print management programs that reduce cost, increase employee productivity, and meet and exceed patient care standards.

Auxilio serves a national portfolio of nearly 220 hospital campuses and manages over 1.5 billion documents annually from over 90,000 devices, supporting over 280,000 caregivers. Auxilio’s Managed Print Services’ business model is vendor neutral, provides a dedicated resident team and is exclusive to the healthcare industry.

Through its Cybersecurity Professional Services Group, Redspin (a subsidiary of Auxilio) provides an end-to-end security offering that specifically addresses hospital security challenges or when a breach has occurred. Redspin’s fully comprehensive portfolio of services and technology includes penetration testing, HIPAA security risk assessments, security program strategy, and a SaaS technology solution, Redspin™ Risk Manager to more than 140 hospitals. This complete service offering of Redspin is unique to the marketplace and helps ensure enterprise-wide security and improved patient experiences through its ability to mitigate risk and improve efficiency across the hospital or health system.

For more information about Auxilio, visit http://www.auxilioinc.com.

About LD Micro

LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. What started out as a newsletter highlighting unique companies has transformed into an event platform hosting several influential conferences annually (Invitational, Summit, and Main Event).

In 2015, LDM launched the first pure microcap index (the LDMi) to exclusively provide intraday information on the entire sector. LD will continue to provide valuable tools for the benefit of everyone in the small and microcap universe.

For those interested in attending, please contact David Scher at david@ldmicro.com or visit www.ldmicro.com for more information.

Contact:

Investor Relations:
MZ North America
Mike Cole, 949-259-4988
Vice President
mike.cole@mzgroup.us
www.mzgroup.us

SOURCE: Auxilio via LD Micro

ReleaseID: 440707

LOS ANGELES, CA / ACCESSWIRE / June 3, 2016 / Oxis Biotech Inc., a wholly owned subsidiary of Oxis International Inc. (OTCQB: OXIS and Euronext Paris: OXI.PA), announced that CEO Tony Cataldo will be presenting at the LD Micro Invitational Conference on June 7, 2016, at 3:00pm PST. The conference will be held on June 7-9 at the Luxe Hotel on Sunset Boulevard in Los Angeles, California.

The LD Micro Invitational is one of the most influential venues in the micro-cap world today. Oxis will join 200 other companies for three days of presentations and private meetings.

CEO Tony Cataldo said, “We have spent a lot of time developing our assets and gathering pristine data. I believe the LD Micro Invitational is the perfect venue to present all of the Company’s recent accomplishments and ongoing developments.”

About Oxis International, Inc.

Oxis International, Inc., through its subsidiary Oxis Biotech, Inc., is an immuno-oncology focused company developing innovative drugs focused on the treatment of cancer and other unmet medical needs. OXIS’ lead drug candidate, OXS-1550 (DT2219ARL), is a novel bispecific scFv recombinant fusion protein-drug conjugate composed of the variable regions of the heavy and light chains of anti-CD19 and anti-CD22 antibodies and a modified form of diphtheria toxin as its cytotoxic drug payload. OXS-1550 targets cancer cells expressing the CD19 receptor or CD22 receptor or both receptors. When OXS-2175 binds to cancer cells, the cancer cells internalize the drug and are killed due to the action of the drug’s cytotoxic payload. OXS-1550 has demonstrated success in early human clinical trials in patients with relapsed/refractory B-cell lymphoma or leukemia. OXS-4235 is a small molecule therapeutic candidate targeting the treatment of multiple myeloma and associated osteolytic lesions. In in vitro and in vivo models of multiple myeloma and osteoporosis, OXS-4235 demonstrated the ability to kill multiple myeloma cells, and decrease osteolytic lesions in bone. OXIS’ lead drug candidate, OXS-2175, is a small molecule therapeutic candidate targeting the treatment of triple-negative breast cancer (TNBC). In in vitro and in vivo models of TNBC, OXS-2175 demonstrated the ability to inhibit metastasis. For more information about Oxis Biotech and it product pipeline, please visit http://www.oxis.com.

Forward-Looking Statements

Except for historical information contained herein, the statements in this release are forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are inherently unreliable and actual results may differ materially. Examples of forward-looking statements in this news release include statements regarding the payment of dividends, marketing and distribution plans, development activities and anticipated operating results. Factors which could cause actual results to differ materially from these forward-looking statements include such factors as the Company’s ability to accomplish its business initiatives, significant fluctuations in marketing expenses and ability to achieve and expand significant levels of revenues, or recognize net income, from the sale of its products and services, as well as the introduction of competing products, or management’s ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and other information that may be detailed from time to time in the Company’s filings with the United States Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

SOURCE: Oxis International, Inc.

ReleaseID: 440722